Sascha Cornelis Antonius Theodorus Verbruggen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sascha Cornelis Antonius Theodorus Verbruggen has a total of 190 co-authors. Here are the top co-authors by number of shared publications:
- Koen Felix Maria Joosten
Department of Neonatal and Paediatric Intensive Care, Erasmus MC - Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, Netherlands
23 shared publications - Greet Van Den Berghe
Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium
21 shared publications - Ilse Vanhorebeek
Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium
17 shared publications - Frédéric Victor Valla
Nutrition Support Team, Endocrinology and Nutrition Department, Hospices Civils de Lyon, Lyon, France
7 shared publications - Karlien Veldscholte
Department of Neonatal and Paediatric Intensive Care, Division of Paediatric Intensive Care, Erasmus MC Sophia Children's Hospital, Rotterdam, the Netherlands
7 shared publications - Fabian Güiza
Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium
6 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 497
Increased ureagenesis revealing metabolic intolerance to enhanced nutrition in the PICU: a secondary analysis of the PEPaNIC RCT
As compared with withholding parenteral nutrition (PN) for one week (late-PN), early supplementation of insufficient enteral nutrition with PN (early-PN) i
- 25 September 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 497
Open AccessIncreased ureagenesis revealing metabolic intolerance to enhanced nutrition in the PICU: a secondary analysis of the PEPaNIC RCT
As compared with withholding parenteral nutrition (PN) for one week (late-PN), early supplementation of insufficient enteral nutrition with PN (early-PN) i
- Open Access
- 30 July 2026
- Published by CABI Publishing
Embase.com search for hospital-based interventions to reduce drug waste: a scoping review with a focus on the paediatric intensive care unit.
This search was developed for a scoping review of hospital-based interventions aimed at reducing medication waste, with a particular focus on the paediatric intensive care unit and related hospital-pharmacy processes. The primary objective was to identify interventions targeting drug waste during the prescription, dispensing, or administration phases of the medication-use process. The secondary objective was to compare reported effects on the quantity of drug waste, economic costs, and environmental impacts. A targeted search was conducted in Embase via Embase.com from database inception to 7 April 2025. The strategy combined Emtree headings and free-text terms relating to drugs, medication-waste reduction, hospitals, hospital pharmacy, and intensive care. Broad hospital and intensive-care terms were deliberately used rather than limiting the search to paediatric intensive care, to identify interventions potentially transferable to the PICU setting. No date or language restrictions were applied. Conference abstracts and conference reviews were excluded in the electronic search syntax. Reference lists of included studies and relevant review articles were subsequently screened to identify additional eligible primary studies. The electronic Embase search retrieved 459 records. Reference-list screening was conducted separately and was not part of the electronic search syntax. The scoping review was conducted and reported in accordance with the PRISMA extension for Scoping Reviews.
- 30 July 2026
- Published by CABI Publishing
Open AccessEmbase.com search for hospital-based interventions to reduce drug waste: a scoping review with a focus on the paediatric intensive care unit.
This search was developed for a scoping review of hospital-based interventions aimed at reducing medication waste, with a particular focus on the paediatric intensive care unit and related hospital-pharmacy processes. The primary objective was to identify interventions targeting drug waste during the prescription, dispensing, or administration phases of the medication-use process. The secondary objective was to compare reported effects on the quantity of drug waste, economic costs, and environmental impacts. A targeted search was conducted in Embase via Embase.com from database inception to 7 April 2025. The strategy combined Emtree headings and free-text terms relating to drugs, medication-waste reduction, hospitals, hospital pharmacy, and intensive care. Broad hospital and intensive-care terms were deliberately used rather than limiting the search to paediatric intensive care, to identify interventions potentially transferable to the PICU setting. No date or language restrictions were applied. Conference abstracts and conference reviews were excluded in the electronic search syntax. Reference lists of included studies and relevant review articles were subsequently screened to identify additional eligible primary studies. The electronic Embase search retrieved 459 records. Reference-list screening was conducted separately and was not part of the electronic search syntax. The scoping review was conducted and reported in accordance with the PRISMA extension for Scoping Reviews.
- Open Access
- 15 April 2026
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 10 (1)
Correlation of parent-reported physical health-related quality-of-life with quantitatively measured physical function of former critically ill children
Background: Many children admitted to a pediatric intensive-care-unit (PICU) show impaired physical function years later. Testing physical function clinically is time-consuming and expensive, hampering routine follow-up. We investigated whether subjective parent-reported physical health-related quality-of-life correlates with and may replace objectively measured physical function of former PICU-patients. Methodology: This secondary analysis of the PEPaNIC-RCT included 517 former PICU-patients with physical function tests and parent-reported health-related quality-of-life 4 years later. Parents scored physical function, bodily pain, general health and physical role functioning with questionnaires. Physical function tests included handgrip-strength, timed up-and-go-test, 6-minute-walk-test, and accelerometry. Questionnaire-items and test-scores were correlated with Pearson/Spearman correlation. Results: Parent-reported physical function correlated moderately with daily time in sedentary state (ρ=-0.300, p < 0.0001), daily sedentary bouts ( R =-0.330, p < 0.0001) and daily steps/hour monitored ( R = 0.303, p < 0.0001), and weakly with handgrip-strength, physical activity energy expenditure, time in certain activity-intensity and daily steps (ρ/ R = 0.185–0.289, p ≤ 0.019). Parent-reported general health (ρ/ R =-0.228 to 0.296, p ≤ 0.033) and physical role functioning (ρ/ R =-0.269 to 0.240, p ≤ 0.038) correlated weakly with roughly the same measured physical functions. Parent-reported bodily pain correlated weakly with daily sedentary bouts ( R =-0.143, p = 0.024) and daily steps/hour monitored ( R = 0.145, p = 0.022). Correlations among physical function test scores were mostly weak. Conclusions: Several aspects of subjective parent-reported physical health-related quality-of-life correlated with former PICU-patients’ performance on physical function tests. The mostly weak strength of the correlations suggest that interrogated physical function cannot simply replace clinical testing. Nevertheless, when resources for clinical testing are lacking, interrogating physical function could still be valuable to get an idea about long-term physical functioning.
- 15 April 2026
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 10 (1)
Open AccessCorrelation of parent-reported physical health-related quality-of-life with quantitatively measured physical function of former critically ill children
Background: Many children admitted to a pediatric intensive-care-unit (PICU) show impaired physical function years later. Testing physical function clinically is time-consuming and expensive, hampering routine follow-up. We investigated whether subjective parent-reported physical health-related quality-of-life correlates with and may replace objectively measured physical function of former PICU-patients. Methodology: This secondary analysis of the PEPaNIC-RCT included 517 former PICU-patients with physical function tests and parent-reported health-related quality-of-life 4 years later. Parents scored physical function, bodily pain, general health and physical role functioning with questionnaires. Physical function tests included handgrip-strength, timed up-and-go-test, 6-minute-walk-test, and accelerometry. Questionnaire-items and test-scores were correlated with Pearson/Spearman correlation. Results: Parent-reported physical function correlated moderately with daily time in sedentary state (ρ=-0.300, p < 0.0001), daily sedentary bouts ( R =-0.330, p < 0.0001) and daily steps/hour monitored ( R = 0.303, p < 0.0001), and weakly with handgrip-strength, physical activity energy expenditure, time in certain activity-intensity and daily steps (ρ/ R = 0.185–0.289, p ≤ 0.019). Parent-reported general health (ρ/ R =-0.228 to 0.296, p ≤ 0.033) and physical role functioning (ρ/ R =-0.269 to 0.240, p ≤ 0.038) correlated weakly with roughly the same measured physical functions. Parent-reported bodily pain correlated weakly with daily sedentary bouts ( R =-0.143, p = 0.024) and daily steps/hour monitored ( R = 0.145, p = 0.022). Correlations among physical function test scores were mostly weak. Conclusions: Several aspects of subjective parent-reported physical health-related quality-of-life correlated with former PICU-patients’ performance on physical function tests. The mostly weak strength of the correlations suggest that interrogated physical function cannot simply replace clinical testing. Nevertheless, when resources for clinical testing are lacking, interrogating physical function could still be valuable to get an idea about long-term physical functioning.
- Open Access
- 12 February 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 74
Hypophosphatemia as a biomarker of metabolic intolerance to enhanced nutrition in the PICU: a secondary analysis of the PEPaNIC RCT
The PEPaNIC RCT showed that early supplementation of insufficient enteral nutrition by parenteral nutrition (early-PN) worsened outcome of critically ill children as compared with withholding PN for 1 week (late-PN). The best timing to initiate nutritional support in the pediatric intensive care unit (PICU) remains unclear. In adults, declining phosphate levels may identify patients who are particularly harmed by early-PN. We therefore assessed whether early hypophosphatemia in critically ill children may indicate metabolic intolerance to nutrition. In this secondary analysis of the PEPaNIC RCT (n = 1440), we investigated whether development of hypophosphatemia statistically interacts with the randomized intervention for its impact on clinical outcome, adjusting for baseline risk factors. Outcomes of interest included the incidence of new infections and the duration of PICU dependency as primary endpoints, 90-day mortality as safety endpoint, and duration of mechanical ventilation and of hospital stay as secondary endpoints. Subsequently, the impact of early-PN vs. late-PN in patients with and without early hypophosphatemia was assessed. Analyses were performed for phosphate abnormalities on PICU day 1 and 2, with and without imputing 20.3% (day 1) or 22.0% (day 2) missing phosphate data. Of patients with available phosphate measurements, 19.9% (211/1060) and 27.5% (243/883) developed hypophosphatemia on day 1 and day 2, respectively. Day 1 hypophosphatemia did not interact with the randomized intervention for any studied outcome. On day 2, hypophosphatemia interacted with randomization for risk of new infection (P = 0.031), likelihood of earlier live PICU discharge (P = 0.030), and time to live weaning from mechanical ventilation (P = 0.025). Harm by early-PN was more pronounced in patients with hypophosphatemia than in those without. Results after imputing missing phosphate data were similar, with an additional interaction for 90-day mortality (P = 0.038) revealing higher mortality with early-PN in patients with hypophosphatemia. Development of hypophosphatemia may identify critically ill children who are particularly harmed by early-PN. This opens perspectives for its use as a biomarker of metabolic intolerance to enhanced nutrition, which requires further investigation. ClinicalTrials.gov NCT01536275, registered February 2012.
- 12 February 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 74
Open AccessHypophosphatemia as a biomarker of metabolic intolerance to enhanced nutrition in the PICU: a secondary analysis of the PEPaNIC RCT
The PEPaNIC RCT showed that early supplementation of insufficient enteral nutrition by parenteral nutrition (early-PN) worsened outcome of critically ill children as compared with withholding PN for 1 week (late-PN). The best timing to initiate nutritional support in the pediatric intensive care unit (PICU) remains unclear. In adults, declining phosphate levels may identify patients who are particularly harmed by early-PN. We therefore assessed whether early hypophosphatemia in critically ill children may indicate metabolic intolerance to nutrition. In this secondary analysis of the PEPaNIC RCT (n = 1440), we investigated whether development of hypophosphatemia statistically interacts with the randomized intervention for its impact on clinical outcome, adjusting for baseline risk factors. Outcomes of interest included the incidence of new infections and the duration of PICU dependency as primary endpoints, 90-day mortality as safety endpoint, and duration of mechanical ventilation and of hospital stay as secondary endpoints. Subsequently, the impact of early-PN vs. late-PN in patients with and without early hypophosphatemia was assessed. Analyses were performed for phosphate abnormalities on PICU day 1 and 2, with and without imputing 20.3% (day 1) or 22.0% (day 2) missing phosphate data. Of patients with available phosphate measurements, 19.9% (211/1060) and 27.5% (243/883) developed hypophosphatemia on day 1 and day 2, respectively. Day 1 hypophosphatemia did not interact with the randomized intervention for any studied outcome. On day 2, hypophosphatemia interacted with randomization for risk of new infection (P = 0.031), likelihood of earlier live PICU discharge (P = 0.030), and time to live weaning from mechanical ventilation (P = 0.025). Harm by early-PN was more pronounced in patients with hypophosphatemia than in those without. Results after imputing missing phosphate data were similar, with an additional interaction for 90-day mortality (P = 0.038) revealing higher mortality with early-PN in patients with hypophosphatemia. Development of hypophosphatemia may identify critically ill children who are particularly harmed by early-PN. This opens perspectives for its use as a biomarker of metabolic intolerance to enhanced nutrition, which requires further investigation. ClinicalTrials.gov NCT01536275, registered February 2012.
- Open Access
- 24 November 2025
- Published by Springer Nature in Intensive Care Medicine – Paediatric and Neonatal
- Vol. 3 (1)
Uptake of the 2020 ESPNIC nutrition recommendations across European pediatric intensive care units
Background: The European Society of Pediatric and Neonatal Intensive Care (ESPNIC) published a systematic review with clinical recommendations around nutritional practice in Pediatric Intensive Care Units (PICUs) in 2020. Four years later we wanted to assess PICUs the perceived uptake of these recommendations across Europe. Methods: A cross-sectional E-survey conducted in July-September 2024. European PICUs (1 response per unit) rated their implementation of each recommendation as fully, partly or not implemented at all. Results: Fifty-three different PICUs from 13 European countries completed the survey. Most 36/53 (67.9%) respondents were PICU consultants, from general PICUs 24/53 (45.2%) and mixed cardiac and general PICUs 19/53 (35.8%). Of the 27 recommendations assessed, ‘full implementation’ was highest for use of a composite lipid formulation 47/53 (88.6%) and the lowest 9/53 (16.9%) for taking anthropometric measurements. The recommendations most frequently reported as ‘not implemented at all’ were measuring energy expenditure by indirect calorimetry 37/53 (69.8%), measuring gastric residuals to guide feeding 13/53 (24.5%), using the recommended Schofield equation to predict energy requirements12/53 (22.6%), using anthropometry to assess nutritional status 10/53 (18.8%) and delaying PN up to the first 7 days of admission 10/53 (18.8%). Conclusion: Perceived uptake of the ESPNIC recommendations varied across European PICUs. Many of the recommendations were perceived to have been partly implemented, but this survey highlights areas for further education and research.
- 24 November 2025
- Published by Springer Nature in Intensive Care Medicine – Paediatric and Neonatal
- Vol. 3 (1)
Open AccessUptake of the 2020 ESPNIC nutrition recommendations across European pediatric intensive care units
Background: The European Society of Pediatric and Neonatal Intensive Care (ESPNIC) published a systematic review with clinical recommendations around nutritional practice in Pediatric Intensive Care Units (PICUs) in 2020. Four years later we wanted to assess PICUs the perceived uptake of these recommendations across Europe. Methods: A cross-sectional E-survey conducted in July-September 2024. European PICUs (1 response per unit) rated their implementation of each recommendation as fully, partly or not implemented at all. Results: Fifty-three different PICUs from 13 European countries completed the survey. Most 36/53 (67.9%) respondents were PICU consultants, from general PICUs 24/53 (45.2%) and mixed cardiac and general PICUs 19/53 (35.8%). Of the 27 recommendations assessed, ‘full implementation’ was highest for use of a composite lipid formulation 47/53 (88.6%) and the lowest 9/53 (16.9%) for taking anthropometric measurements. The recommendations most frequently reported as ‘not implemented at all’ were measuring energy expenditure by indirect calorimetry 37/53 (69.8%), measuring gastric residuals to guide feeding 13/53 (24.5%), using the recommended Schofield equation to predict energy requirements12/53 (22.6%), using anthropometry to assess nutritional status 10/53 (18.8%) and delaying PN up to the first 7 days of admission 10/53 (18.8%). Conclusion: Perceived uptake of the ESPNIC recommendations varied across European PICUs. Many of the recommendations were perceived to have been partly implemented, but this survey highlights areas for further education and research.
- Open Access
- 23 November 2025
- Published by Springer Nature in Clinical Epigenetics
- Vol. 18 (1)
Aberrant DNA methylation within circadian entrainment and clock genes two years after pediatric critical illness is associated with impaired physical and neurocognitive development
Pediatric critical illness can disrupt circadian rhythms, potentially leading to long-term deficits in growth, neurocognition, and behavior. Disturbances in circadian rhythms have been associated with altered gene expression and DNA methylation. We investigated long-term DNA methylation alterations in circadian entrainment and clock genes in children previously admitted to the pediatric intensive care unit (PICU), the influence of parenteral nutrition (PN) timing hereon and their associations with long-term health outcomes. This study is a secondary analysis of the PEPaNIC randomized controlled trial (RCT) and its two-year follow-up. The PEPaNIC-RCT randomized critically ill children to early initiation of supplemental PN within the first 24 h or its omission in the first week of PICU admission. DNA methylation of 127 circadian entrainment and clock genes was studied in buccal mucosa DNA of former PICU patients (n = 818) and matched healthy children (n = 392) at the two-year follow-up using Infinium® HumanMethylation EPIC BeadChips. Multivariable linear models were used to identify differential methylation between former patients and controls and their association with randomization group and outcomes at two-year follow-up. Former PICU patients showed 61 differentially methylated CpG sites (DMPs) within 34 of the genes, with 60 (98.4%) showing hypomethylation as compared with healthy children. Omitting early PN during PICU stay did not affect CpG site methylation. 702 associations (34.9%) were observed between abnormal DNA methylation and adverse long-term health and developmental outcomes, most notably visual-motor integration (47 DMPs, 77%), height (46 DMPs, 75%) and total IQ (46 DMPs, 75%). Former PICU patients exhibited altered DNA methylation in circadian entrainment and clock genes compared to healthy children, and this was associated with impaired growth, neurocognition and behavioral problems at two-year follow-up. Disruptions in circadian entrainment and clock gene methylation may contribute to the adverse long-term health consequences that children experience after critical illness.
- 23 November 2025
- Published by Springer Nature in Clinical Epigenetics
- Vol. 18 (1)
Open AccessAberrant DNA methylation within circadian entrainment and clock genes two years after pediatric critical illness is associated with impaired physical and neurocognitive development
Pediatric critical illness can disrupt circadian rhythms, potentially leading to long-term deficits in growth, neurocognition, and behavior. Disturbances in circadian rhythms have been associated with altered gene expression and DNA methylation. We investigated long-term DNA methylation alterations in circadian entrainment and clock genes in children previously admitted to the pediatric intensive care unit (PICU), the influence of parenteral nutrition (PN) timing hereon and their associations with long-term health outcomes. This study is a secondary analysis of the PEPaNIC randomized controlled trial (RCT) and its two-year follow-up. The PEPaNIC-RCT randomized critically ill children to early initiation of supplemental PN within the first 24 h or its omission in the first week of PICU admission. DNA methylation of 127 circadian entrainment and clock genes was studied in buccal mucosa DNA of former PICU patients (n = 818) and matched healthy children (n = 392) at the two-year follow-up using Infinium® HumanMethylation EPIC BeadChips. Multivariable linear models were used to identify differential methylation between former patients and controls and their association with randomization group and outcomes at two-year follow-up. Former PICU patients showed 61 differentially methylated CpG sites (DMPs) within 34 of the genes, with 60 (98.4%) showing hypomethylation as compared with healthy children. Omitting early PN during PICU stay did not affect CpG site methylation. 702 associations (34.9%) were observed between abnormal DNA methylation and adverse long-term health and developmental outcomes, most notably visual-motor integration (47 DMPs, 77%), height (46 DMPs, 75%) and total IQ (46 DMPs, 75%). Former PICU patients exhibited altered DNA methylation in circadian entrainment and clock genes compared to healthy children, and this was associated with impaired growth, neurocognition and behavioral problems at two-year follow-up. Disruptions in circadian entrainment and clock gene methylation may contribute to the adverse long-term health consequences that children experience after critical illness.
- Open Access
- 4 March 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-7
Alterations in the lipid profile of critically ill children in relation to outcome
Critically ill adults typically develop hypocholesterolemia, associated with poor outcome. Whether similar alterations occur in critically ill children is less clear. In secondary analyses of the PEPaNIC RCT (n = 1440), we first documented the time course of plasma cholesterol and triglyceride concentrations, and the effect of randomization to early-parenteral-nutrition (early-PN) or late-PN hereon, for 96 matched critically ill children staying ≥ 5 days in PICU. Second, for 1165 children with available admission plasma samples, lipid profiles were determined and their independent associations with outcome (time to live PICU discharge, new infection and 90-day mortality) were assessed with Multivariable Cox proportional hazard and logistic regression, adjusting for baseline risk factors. Plasma HDL-cholesterol, LDL-cholesterol, total-cholesterol and triglycerides were low throughout the 5 PICU days, with only HDL-cholesterol further decreasing over time (P < 0.0001) and without effect of randomization to early-PN or late-PN, and with admission values lower in infants than older children and in patients with infection (P < 0.05). Lower admission HDL- and total-cholesterol concentrations were independently associated with a lower likelihood of an earlier live PICU discharge (P < 0.001) and with a higher risk of 90-day mortality (P ≤ 0.01), whereas higher plasma triglycerides were independently associated with higher risk of 90-day mortality (P = 0.004). Low admission plasma HDL-cholesterol was independently associated with a higher risk of acquiring a new infection (P = 0.05). Critically ill children presented with low circulating levels of lipids. Low plasma cholesterol concentrations were associated with poor outcomes, most robustly for HDL-cholesterol. Whether these associations are causal or casual requires further investigation.
- 4 March 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-7
Open AccessAlterations in the lipid profile of critically ill children in relation to outcome
Critically ill adults typically develop hypocholesterolemia, associated with poor outcome. Whether similar alterations occur in critically ill children is less clear. In secondary analyses of the PEPaNIC RCT (n = 1440), we first documented the time course of plasma cholesterol and triglyceride concentrations, and the effect of randomization to early-parenteral-nutrition (early-PN) or late-PN hereon, for 96 matched critically ill children staying ≥ 5 days in PICU. Second, for 1165 children with available admission plasma samples, lipid profiles were determined and their independent associations with outcome (time to live PICU discharge, new infection and 90-day mortality) were assessed with Multivariable Cox proportional hazard and logistic regression, adjusting for baseline risk factors. Plasma HDL-cholesterol, LDL-cholesterol, total-cholesterol and triglycerides were low throughout the 5 PICU days, with only HDL-cholesterol further decreasing over time (P < 0.0001) and without effect of randomization to early-PN or late-PN, and with admission values lower in infants than older children and in patients with infection (P < 0.05). Lower admission HDL- and total-cholesterol concentrations were independently associated with a lower likelihood of an earlier live PICU discharge (P < 0.001) and with a higher risk of 90-day mortality (P ≤ 0.01), whereas higher plasma triglycerides were independently associated with higher risk of 90-day mortality (P = 0.004). Low admission plasma HDL-cholesterol was independently associated with a higher risk of acquiring a new infection (P = 0.05). Critically ill children presented with low circulating levels of lipids. Low plasma cholesterol concentrations were associated with poor outcomes, most robustly for HDL-cholesterol. Whether these associations are causal or casual requires further investigation.
- Open Access
- 6 February 2025
- Published by Elsevier in Clinical Nutrition
- Vol. 46, 169-180
On how to feed critically ill children in intensive care: A slowly shifting paradigm
- 6 February 2025
- Published by Elsevier in Clinical Nutrition
- Vol. 46, 169-180
Open AccessOn how to feed critically ill children in intensive care: A slowly shifting paradigm
- Open Access
- 23 February 2024
- Published by Springer Nature in Clinical Epigenetics
- Vol. 16 (1) , 1-15
Abnormal DNA methylation within HPA-axis genes years after paediatric critical illness
Background: Critically ill children suffer from impaired physical/neurocognitive development 2 years later. Glucocorticoid treatment alters DNA methylation within the hypothalamus–pituitary–adrenal (HPA) axis which may impair normal brain development, cognition and behaviour. We tested the hypothesis that paediatric-intensive-care-unit (PICU) patients, sex- and age-dependently, show long-term abnormal DNA methylation within the HPA-axis layers, possibly aggravated by glucocorticoid treatment in the PICU, which may contribute to the long-term developmental impairments. Results: In a pre-planned secondary analysis of the multicentre PEPaNIC-RCT and its 2-year follow-up, we identified differentially methylated positions and differentially methylated regions within HPA-axis genes in buccal mucosa DNA from 818 former PICU patients 2 years after PICU admission (n = 608 no glucocorticoid treatment; n = 210 glucocorticoid treatment) versus 392 healthy children and assessed interaction with sex and age, role of glucocorticoid treatment in the PICU and associations with long-term developmental impairments. Adjusting for technical variation and baseline risk factors and correcting for multiple testing (false discovery rate < 0.05), former PICU patients showed abnormal DNA methylation of 26 CpG sites (within CRHR1, POMC, MC2R, NR3C1, FKBP5, HSD11B1, SRD5A1, AKR1D1, DUSP1, TSC22D3 and TNF) and three DNA regions (within AVP, TSC22D3 and TNF) that were mostly hypomethylated. These abnormalities were sex-independent and only partially age-dependent. Abnormal methylation of three CpG sites within FKBP5 and one CpG site within SRD5A1 and AKR1D1 was partly attributable to glucocorticoid treatment during PICU stay. Finally, abnormal methylation within FKBP5 and AKR1D1 was most robustly associated with long-term impaired development. Conclusions: Two years after critical illness in children, abnormal methylation within HPA-axis genes was present, predominantly within FKBP5 and AKR1D1, partly attributable to glucocorticoid treatment in the PICU, and explaining part of the long-term developmental impairments. These data call for caution regarding liberal glucocorticoid use in the PICU.
- 23 February 2024
- Published by Springer Nature in Clinical Epigenetics
- Vol. 16 (1) , 1-15
Open AccessAbnormal DNA methylation within HPA-axis genes years after paediatric critical illness
Background: Critically ill children suffer from impaired physical/neurocognitive development 2 years later. Glucocorticoid treatment alters DNA methylation within the hypothalamus–pituitary–adrenal (HPA) axis which may impair normal brain development, cognition and behaviour. We tested the hypothesis that paediatric-intensive-care-unit (PICU) patients, sex- and age-dependently, show long-term abnormal DNA methylation within the HPA-axis layers, possibly aggravated by glucocorticoid treatment in the PICU, which may contribute to the long-term developmental impairments. Results: In a pre-planned secondary analysis of the multicentre PEPaNIC-RCT and its 2-year follow-up, we identified differentially methylated positions and differentially methylated regions within HPA-axis genes in buccal mucosa DNA from 818 former PICU patients 2 years after PICU admission (n = 608 no glucocorticoid treatment; n = 210 glucocorticoid treatment) versus 392 healthy children and assessed interaction with sex and age, role of glucocorticoid treatment in the PICU and associations with long-term developmental impairments. Adjusting for technical variation and baseline risk factors and correcting for multiple testing (false discovery rate < 0.05), former PICU patients showed abnormal DNA methylation of 26 CpG sites (within CRHR1, POMC, MC2R, NR3C1, FKBP5, HSD11B1, SRD5A1, AKR1D1, DUSP1, TSC22D3 and TNF) and three DNA regions (within AVP, TSC22D3 and TNF) that were mostly hypomethylated. These abnormalities were sex-independent and only partially age-dependent. Abnormal methylation of three CpG sites within FKBP5 and one CpG site within SRD5A1 and AKR1D1 was partly attributable to glucocorticoid treatment during PICU stay. Finally, abnormal methylation within FKBP5 and AKR1D1 was most robustly associated with long-term impaired development. Conclusions: Two years after critical illness in children, abnormal methylation within HPA-axis genes was present, predominantly within FKBP5 and AKR1D1, partly attributable to glucocorticoid treatment in the PICU, and explaining part of the long-term developmental impairments. These data call for caution regarding liberal glucocorticoid use in the PICU.
- Open Access
- 9 January 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (2) , 543-551
Plasma and red blood cell concentrations of zinc, copper, selenium and magnesium in the first week of paediatric critical illness
- 9 January 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (2) , 543-551
Open AccessPlasma and red blood cell concentrations of zinc, copper, selenium and magnesium in the first week of paediatric critical illness